T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes

Cancer Research

Volumn 57, Issue 23, 1997, Pages 5320-5327

  Cole, David J ^a,d   Wilson, Michael C ^a   Rivoltini, Licia ^b   Custer, Mary ^c   Nishimura, Michael I ^c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c NATIONAL CANCER INSTITUTE   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ADOPTIVE TRANSFER; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CELL STIMULATION; EFFECTOR CELL; GENE REARRANGEMENT; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN FAMILY; T LYMPHOCYTE ACTIVATION; TUMOR ASSOCIATED LEUKOCYTE;

AMINO ACID SEQUENCE; ANTIGENS, NEOPLASM; BASE SEQUENCE; CELLS, CULTURED; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; MELANOMA; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, T-CELL; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; SEQUENCE HOMOLOGY, NUCLEIC ACID; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0030697180     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Darrow, T. L., Slinghoff, C. L., Jr., and Siegler, H. F. The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes: evidence for shared tumor-antigens. J. Immunol., 142: 3329-3335, 1989.
2. Kawakami, Y., Zakut, R., Topalian, S. L., Stotter, H., and Rosenberg, S. A. Recognition by tumor-infiltrating lymphocytes in HLA-A2.1 -transfected melanomas. J. Immunol., 148: 638-643, 1992.
3. Topalian, S. L., Solomon, D., and Rosenberg, S. A. Tumor specific cytolysis by lymphocytes infiltrating human melanomas. J. Immunol., 142: 3714-3724, 1989.
4. Rosenberg, S. A., Speiss, P., and Lafreniere, R. A. A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science (Washington DC), 233: 1318-1321, 1986.
5. Rosenberg, S. A., Packard, B. S., Aebersold, P. M., Solomon, D., Topalian, S. L., Toy, S. T., Simon, P., Lotze, M. T., Yang, J. C., Seipp, C. A., Simpson, C., Carter, C., Bock, S., Schwartzentruber, D., Wei, J. P., and White, D. E. Use of tumor infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. N. Engl. J. Med., 319: 1676-1680, 1988.
6. Topalian, S. L., Solomon, D., Avis, F. P., Chang, A. E., Freerksen, D. L., Linehan, W. M., Lotze, M. T., Robertson, C. N., Seipp, C. A., Simon, P., Simpson, C. G., and Rosenberg, S. A. Immunotherapy of patients with advanced cancer using tumorinfiltrating lymphocytes and recombinant interleukin-2: a pilot study. J. Clin. Oncol., 6: 839-853, 1988.
7. Van den Eynde, B., Lethe, B., Van Pel, A., De Plaen, E., and Boon, T. The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice. J. Exp. Med., 173: 1373-1377, 1991.
8. Mandelboim, O., Berke, G., Fridkin, M., Feldman, M., Elsenstein, M., and Eisenbach, L. CTL induction by a tumor-associated antigen octapeptide derived from a murine lung carcinoma. Nature (Lond.), 369: 67-71, 1994.
9. Van der Bruggen, P., Traversari, P. C., Chomez, P., Lurquin, C., DePlaen, E., Van den Eynde, B., Knuth, A., and Boon, T. A gene encoding an antigen recognized by cyitolytic T-lymphocytes on a human melanoma. Science (Washington DC), 254: 1643-1647, 1991.
10. Brichard, V., Van Pel, W., Wolfel, T., DePlaen, E., Lethe, B., Coulie, P., and Boon, T. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T-lymphocytes on HLA-A2 melanomas. J. Exp. Med., 489-495: 1993.
11. Gaugler, B., Van den Eynde, B., Van der Bruggen, P., Romero, P., Gaforio, J. J., De Plaen, E., Lethe, B., Brasseur, F., and Boon, T. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T-lymphocytes. J. Exp. Med., 179: 921-930, 1994.
12. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. R., Rivoltini, L., Topalian, S. L., Mili, T., and Rosenberg, S. A. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T-cells infiltrating into tumor. Proc. Natl. Acad. Sci., 91: 3515-3519, 1994.
13. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. R., Sakaguchi, K., Appella, E., Yannelli, J. R., Adema, G. J., Mjiki, T., and Rosenberg, S. A. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA, 91: 6458-6462, 1994.
14. Cox, A. L., Skipper, J., Chen, Y., and Henderson, R. A. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science (Washington DC), 264: 716-719, 1994.
15. Bakker, A. B., Schreurs, W. J., de Boer, A. J., Kawakami, Y., Rosenberg, S. A., Adema, G. J., and Figdor, C. G. Melanocyte lineage-specific antigen gp0100 is recognized by melanoma-derived tumor infiltrating lymphocytes. J. Exp. Med., 179: 1005-1009, 1994.
16. Robbins, P. F., El-Gamil, M., Kawakami, Y. F., Loftus, D., Appella, E., and Rosenberg, S. A. A mutated B-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J. Exp. Med., 183: 1185-1192, 1996.
17. Matis, L. A. The molecular basis of T cell specificity. Annu. Rev. Immunol., 8: 65-82, 1990.
18. Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennet, W. S., Strominger, J. L., and Wiley, D. C. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature (Lond.), 329: 512-518, 1987.
19. Cole, D. J., Weil, D. P., Shilyansky, J., Custer, M., Kawakami, Y., Rosenberg, S. A., and Nishimura, M. I. Characterization of the functional specificity of a cloned T-cell receptor heterodimer recognizing the MART-1 melanoma antigen. Cancer Res., 55: 748-752, 1995.
20. Rosenberg, S. A. The immunotherapy and gene therapy of cancer. J. Clin. Oncol., 10: 180-199, 1992.
21. Rosenberg, S. A. The development of new cancer therapies based on the molecular identification of cancer regression antigens. Cancer J. Sci. Am., 1: 89-100, 1995.
22. Mandelboim, O., Vadai, E., Fridkin, M., Katz-Hillel, A., Feldmen, M., Berke, G., and Eisenbach, L. Regression of established murine carcinoma metastases following vaccination with tumor-associated antigen peptides. Nat. Med., 1: 1179-1183, 1995.
23. Hu, J., Kindsvogel, W., Busby, S., Bailey, M. C., Shi, Y-Y., and Greenberg, P. D. An evaluation of the potential to use tumor-associated antigens as targets for antitumor T-cell therapy using transgenic mice expressing a retroviral antigen in normal lymphoid tissues. J. Exp. Med., 177: 1681-1690, 1993.
24. Rivoltini, L., Kawakami, Y., Sakaguchi, K., Southwood, S., Sette, A., Robbins, P. F., Marincola, F. M., Salgaller, M. L., Yannelli, J. R., Appella, E., and Rosenberg, S. A. Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen. J. Immunol., 154: 2257-2265, 1995.
25. Zitvogel, L., Mayordomo, J. I., Tjandrawan, T., DeLeo, A. B., Clarke, M. R., Lotze, M. T., and Storkus, W. J. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med., 183: 87-97, 1996.
26. Cole, D. J., Gattoni-Celli, S., McClay, E. F., Nabavi, N., Warner, S. N., Newton, D., Woolhiser, C., Wilson, M. C., and Vournakis, J. Characterization of a sustained release delivery system for combined cytokine/peptide based vaccination using a fully acetylated poly-N-acetyl glucosamine matrix. Clin. Cancer Res., 3: 867-873, 1997.
27. Maeurer, M. J., Storkus, W. J., Kirkwood, J. M., and Lotze, M. T. New treatment options for patients with melanoma: review of melanoma-derived T-cell epitopebased peptide vaccines. Melanoma Res., 6: 11-24, 1996.
28. Gattoni-Celli, S., and Cole, D. J. Melanoma-associate tumor antigens and their clinical relevance to immunotherapy. Semin. Oncol., 23: 754-758, 1996.
29. Chomczynski, P., and Sacchi, N. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Anal. Biochem., 18: 156-159, 1987.
30. Nishimura, M. I., Kawakami, Y., Charmley, P., O'Neil, B., Shilyansky, J., Yannelli, J. R., Rosenberg, S. A., and Hood, L. T-cell receptor repertoire in tumor infiltrating lymphocytes. Analysis of melanoma-specific long-term lines. J. Immunother., 16: 85-94, 1994.
31. Sensi, M., Salvi, S., Castelli, C., Maccalli, C., Mazzocchi, A., Mortarini, R., Nicolini, G., Herlyn, M., Parmiani, G., and Anichini, A. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor infiltrating lymphocytes overexpress in vivo the TCR β chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone. J. Exp. Med., 178: 1231-1248, 1993.
32. Shilyansky, J., Nishimura, M. I., Yannelli, J. R., Kawakami, Y., Jacknin, L. S., Charmley, P., and Rosenberg, S. A. T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines. Proc. Natl. Acad. Sci. USA, 91: 2829-2833, 1994.
33. Puisieux, I., Even, J., Pannetier, C., Jotereau, F., Favrot, M., and Kourilsky, P. Oligoclonality of tumor- infiltrating lymphocytes from human melanomas. J. Immunol., 156: 2807-2818, 1994.
34. Ferrandini, L., Roman-Roman, S., Azocar, J., Avril, M. F., Veil, S., Triebel, F., and Hercend, T. Analysis of T-cell receptor α/β variability in lymphocytes infiltrating a melanoma metastasis. Cancer Res., 52: 4649-4652, 1992.
35. Ferrandini, L., Mackensen, A., Genevee, C., Bosq, J., Duvillard, P., Avril, M. F., and Hercend, T. Analysis of T cell receptor variability in tumor infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansion. J. Clin. Invest., 91: 1183-1190, 1993.
36. Weidmann, E., Elder, E. M., Trucco, M., Lotze, M. T., and Whiteside, T. L. Usage of T-cell receptor Vβ chain genes in fresh and cultured tumor-infiltrating lymphocuytes from human melanoma. Int. J. Cancer, 54: 383-90, 1993.
37. Hahne, M., Rimoldi, D., Schroter, M., Romero, P., Schirer, M., French, L. E., Schneider, P., Bornand, T., Fontana, A., Lienard, D., Cerottini, J., and Tschopp, J. Melanoma cell expression of Fas (Apo-1/CD95) ligand: implication for tumor immune escape. Science (Washington DC), 274: 1363-1366, 1996.
38. Lehner, P. J., Wang, E. C., Moss, P. A., Williams, S., Platt, K., Friedman, S. M., Bell, J. I., and Borysiewicz, L. K. Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V β 17 gene segment. J. Exp. Med., 181: 79-91, 1995.
39. Cole, D. J., Weil, D. P, Shamamian, P., Rivoltini, L., Kawakami, Y., Topalian, S. L., Jennings, C., Eliyahu, S., Rosenberg, S. A., and Nishimura, M. I. Identification of MART-1 specific T-cell receptors: T-cells utilizing distinct T-cell receptor variable and joining regions recognize the same tumor epitope. Cancer Res., 54: 5265-5268, 1994.
40. Loftus, D. J., Castelli, C., Clay, T. M., Swarcina, P., Marincola, F. M., Nishimura, M. I., Parmiani, G., Appella, E., and Rivoltini, L. Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35). J. Exp. Med., 184: 647-657, 1996.
41. Wucherpfennig, K. W., and Strominger, J. L. Molecular mimicry in T cell mediated autoimmunity: viral peptides activate human T cell clones specific for mylein basic protein. Cell, 80: 695-705, 1995.
42. Sorger, S. B., Paterson, Y., Fink, P. J., and Hedrick, S. M. T cell receptor junctional regions and the MHC molecule affect the recognition of antigenic peptides by T cell clones. J. Immunol., 144: 1127-1135, 1990.
43. k-restricted T helper hybridomas. J. Immunol., 142: 3298-3304, 1989.
44. Casanova, J. L., Romero, P., Widmann, C., Kourilsky, P., and Maryanski, J. L. T cell receptor genes in a series of class I major histocompatibility complex-restricted cytotoxic T lymphocyte clones specific for a Plasmodium berghei nonapeptide: implications for T cell allelic exclusion and antigen-specific repertoire. J. Exp. Med., 174: 1371-1383, 1991.
45. - peptide specific cytotoxic T lymphocyte clones. J. Immunol., 150: 800-811, 1993.
46. Yanagi, Y., Tishon, A, Lewicki, H., Cubitt, B. A., and Oldstone, M. B. Diversity of T-cell receptors in virus-specific cytotoxic T lymphocytes recognizing three distinct viral epitopes restricted by a single major histocompatibility complex molecule. J. Virol., 66: 2527-2531, 1992.